Clinical trials: study design, endpoints and biomarkers, drug safety, and FDA and ICH guidelines
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Buch |
| Sprache: | English |
| Veröffentlicht: |
Amsterdam
Elsevier, AP
2016
|
| Ausgabe: | Second edition |
| Schlagworte: | |
| Beschreibung: | xxxii, 863 Seiten Diagramme |
| ISBN: | 9780128042175 |
Internformat
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV043858087 | ||
| 003 | DE-604 | ||
| 005 | 20161122 | ||
| 007 | t | ||
| 008 | 161103s2016 |||| |||| 00||| eng d | ||
| 020 | |a 9780128042175 |9 978-0-12-804217-5 | ||
| 035 | |a (OCoLC)965507562 | ||
| 035 | |a (DE-599)BVBBV043858087 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-M49 | ||
| 084 | |a MED 100f |2 stub | ||
| 100 | 1 | |a Brody, Tom |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Clinical trials |b study design, endpoints and biomarkers, drug safety, and FDA and ICH guidelines |c Tom Brody, Ph.D. |
| 250 | |a Second edition | ||
| 264 | 1 | |a Amsterdam |b Elsevier, AP |c 2016 | |
| 300 | |a xxxii, 863 Seiten |b Diagramme | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 650 | 0 | 7 | |a Klinisches Experiment |0 (DE-588)4164223-5 |2 gnd |9 rswk-swf |
| 689 | 0 | 0 | |a Klinisches Experiment |0 (DE-588)4164223-5 |D s |
| 689 | 0 | |8 1\p |5 DE-604 | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-029268259 | ||
| 883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
Datensatz im Suchindex
| _version_ | 1804176736417480704 |
|---|---|
| any_adam_object | |
| author | Brody, Tom |
| author_facet | Brody, Tom |
| author_role | aut |
| author_sort | Brody, Tom |
| author_variant | t b tb |
| building | Verbundindex |
| bvnumber | BV043858087 |
| classification_tum | MED 100f |
| ctrlnum | (OCoLC)965507562 (DE-599)BVBBV043858087 |
| discipline | Medizin |
| edition | Second edition |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01079nam a2200325 c 4500</leader><controlfield tag="001">BV043858087</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20161122 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">161103s2016 |||| |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780128042175</subfield><subfield code="9">978-0-12-804217-5</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)965507562</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV043858087</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-M49</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">MED 100f</subfield><subfield code="2">stub</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Brody, Tom</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Clinical trials</subfield><subfield code="b">study design, endpoints and biomarkers, drug safety, and FDA and ICH guidelines</subfield><subfield code="c">Tom Brody, Ph.D.</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">Second edition</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Amsterdam</subfield><subfield code="b">Elsevier, AP</subfield><subfield code="c">2016</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">xxxii, 863 Seiten</subfield><subfield code="b">Diagramme</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Klinisches Experiment</subfield><subfield code="0">(DE-588)4164223-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Klinisches Experiment</subfield><subfield code="0">(DE-588)4164223-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="8">1\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-029268259</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield></record></collection> |
| id | DE-604.BV043858087 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T07:36:55Z |
| institution | BVB |
| isbn | 9780128042175 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-029268259 |
| oclc_num | 965507562 |
| open_access_boolean | |
| owner | DE-M49 DE-BY-TUM |
| owner_facet | DE-M49 DE-BY-TUM |
| physical | xxxii, 863 Seiten Diagramme |
| publishDate | 2016 |
| publishDateSearch | 2016 |
| publishDateSort | 2016 |
| publisher | Elsevier, AP |
| record_format | marc |
| spelling | Brody, Tom Verfasser aut Clinical trials study design, endpoints and biomarkers, drug safety, and FDA and ICH guidelines Tom Brody, Ph.D. Second edition Amsterdam Elsevier, AP 2016 xxxii, 863 Seiten Diagramme txt rdacontent n rdamedia nc rdacarrier Klinisches Experiment (DE-588)4164223-5 gnd rswk-swf Klinisches Experiment (DE-588)4164223-5 s 1\p DE-604 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk |
| spellingShingle | Brody, Tom Clinical trials study design, endpoints and biomarkers, drug safety, and FDA and ICH guidelines Klinisches Experiment (DE-588)4164223-5 gnd |
| subject_GND | (DE-588)4164223-5 |
| title | Clinical trials study design, endpoints and biomarkers, drug safety, and FDA and ICH guidelines |
| title_auth | Clinical trials study design, endpoints and biomarkers, drug safety, and FDA and ICH guidelines |
| title_exact_search | Clinical trials study design, endpoints and biomarkers, drug safety, and FDA and ICH guidelines |
| title_full | Clinical trials study design, endpoints and biomarkers, drug safety, and FDA and ICH guidelines Tom Brody, Ph.D. |
| title_fullStr | Clinical trials study design, endpoints and biomarkers, drug safety, and FDA and ICH guidelines Tom Brody, Ph.D. |
| title_full_unstemmed | Clinical trials study design, endpoints and biomarkers, drug safety, and FDA and ICH guidelines Tom Brody, Ph.D. |
| title_short | Clinical trials |
| title_sort | clinical trials study design endpoints and biomarkers drug safety and fda and ich guidelines |
| title_sub | study design, endpoints and biomarkers, drug safety, and FDA and ICH guidelines |
| topic | Klinisches Experiment (DE-588)4164223-5 gnd |
| topic_facet | Klinisches Experiment |
| work_keys_str_mv | AT brodytom clinicaltrialsstudydesignendpointsandbiomarkersdrugsafetyandfdaandichguidelines |